Medipost Co Ltd.: Clinical Trials

23 trials sponsored by Medipost Co Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 5 unknown, 2 active not recruiting. 10 Phase 2, 9 Phase 1, 3 Not applicable, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 7, Active not recruiting 2, Unknown 1
Phase 19Completed 7, Unknown 2
Not applicable3Completed 2, Unknown 1
Phase 33Completed 3

Follow Medipost Co Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control
SMUP-IA-01(low-dose), SMUP-IA-01(mid-dose), High Hyal Plus - Knee Osteoarthritis
Phase 2Active not recruitingMedipost Co Ltd.842023-03-202025-02-07
Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis
SMUP-IA-01(low dose), SMUP-IA-01(mid dose), Active Control Group Sodium chloride - Knee Osteoarthritis
Phase 2CompletedMedipost Co Ltd.942022-02-242025-02-05
Exploratory Efficacy Study of NEUROSTEM® in Subjects Who Control Group of NEUROSTEM®
human umbilical cord blood derived mesenchymal stem cells - Alzheimer's Disease
Not applicableUnknownSamsung Medical Center92021-07-122021-07-14
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial
SMUP-IA-01(low-dose), SMUP-IA-01(mid-dose), SMUP-IA-01(high-dose) - Knee Osteoarthritis
Phase 1UnknownMedipost Co Ltd.122020-04-142023-03-15
Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus
CARTISTEM®, Microfracture - Chondral or Osteochondral Lesion of Talus
Phase 3CompletedHyundai Bioland Co., Ltd.1022020-03-032022-11-29
Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis
SMUP-IA-01(low-dose), SMUP-IA-01(mid-dose), SMUP-IA-01(high-dose) - Knee Osteoarthritis
Phase 1CompletedMedipost Co Ltd.122019-10-072021-02-24
Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
PNEUMOSTEM®, normal saline - Bronchopulmonary Dysplasia, BPD
Phase 2Active not recruitingMedipost Co Ltd.602019-07-052025-02-07
Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia
conditioned media of umbilical cord blood-derived stem cells, Placebo - Androgenic Alopecia
Not applicableCompletedMedipost Co Ltd.842018-10-022019-08-12
PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants
PNEUMOSTEM, Placebo - Severe Bronchopulmonary Dysplasia
Phase 2CompletedMedipost Co Ltd.602018-08-132025-01-24
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.
human umbilical cord blood derived mesenchymal stem cells, Normal saline 2mL - Alzheimer's Disease
Phase 1 / Phase 2CompletedMedipost Co Ltd.362017-05-192023-03-15
Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) - a US Study
Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells - Bronchopulmonary Dysplasia
Phase 1 / Phase 2CompletedMedipost, Inc.122015-03-012018-08-16
Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study
PNEUMOSTEM - Bronchopulmonary Dysplasia, Respiratory Tract Infections
CompletedMedipost Co Ltd.82014-04-012018-09-04
Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease
human umbilical cord blood derived mesenchymal stem cells, Normal saline 2mL - Alzheimer's Disease
Phase 1 / Phase 2CompletedMedipost Co Ltd.462014-03-012020-08-28
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial
Pneumostem®, normal saline - Bronchopulmonary Dysplasia
Not applicableCompletedMedipost Co Ltd.622014-01-012020-08-07
Efficacy and Safety Evaluation of Pneumostem® Versus a Control Group for Treatment of BPD in Premature Infants
Pneumostem®, Normal Saline - Bronchopulmonary Dysplasia
Phase 2CompletedMedipost Co Ltd.692013-04-012019-09-06
Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect
CARTISTEM, Microfracture - Degenerative Osteoarthritis, Defect of Articular Cartilage
Phase 3CompletedMedipost Co Ltd.1032012-06-012017-04-20
The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD
NEUROSTEM®-AD - Alzheimer Disease, Dementia
UnknownDuk Lyul Na142012-03-012012-10-01
Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease
Human umbilical cord blood-derived mesenchymal stem cells - Graft-Versus-Host Disease, GVHD
Phase 1 / Phase 2UnknownSamsung Medical Center302012-01-012012-03-16
Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
Pneumostem® - Bronchopulmonary Dysplasia
UnknownSamsung Medical Center92011-09-012019-04-09
The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease
Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells - Dementia of the Alzheimer's Type
Phase 1CompletedMedipost Co Ltd.92011-02-012012-04-23

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Bronchopulmonary Dysplasia (8)  ·  Premature Birth (7)  ·  Alzheimer Disease (5)  ·  Osteoarthritis, Knee (4)  ·  Osteoarthritis (2)  ·  Alopecia (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dementia (1)  ·  Graft vs Host Disease (1)  ·  Hyperplasia (1)  ·  Infant, Newborn, Diseases (1)  ·  Infant, Premature, Diseases (1)  ·  Joint Diseases (1)  ·  Lung Diseases (1)

Interventions

Saline Solution (5)  ·  Arthroplasty, Subchondral (2)  ·  Sodium Chloride (1)

Countries

South Korea (22)  ·  United States (1)

Top investigators

Won-Soon Park, MD, PhD (3)  ·  Ai-Rhan Kim, MD, PhD (2)  ·  Hong-chul Lim, MD, PhD (2)  ·  Myungchul Lee, MD, PhD (2)  ·  Wonsoon Park, MD, PhD (2)  ·  Ai-Rhan Kim (1)  ·  Airhan Kim (1)  ·  Beom-gu Lee, MD, PhD (1)  ·  Chongbum Chang, MD, PhD (1)  ·  Chonghyuk Choi, MD, PhD (1)  ·  Choong-hyuk Choi, MD, PhD (1)  ·  Chul-won Ha, MD, PhD (1)  ·  Duk L. Na, M.D. (1)  ·  Duk L. Na, MD, PhD (1)

Results publications

PMID 41220869, PMID 29854930, PMID 33490296, PMID 33876883, PMID 34521461, PMID 24508444, PMID 28341525, PMID 30992220, PMID 37468918, PMID 37604693, PMID 41814444